Zucapsaicin
As of the edition of 20 October 2026, Zucapsaicin is a small molecule: went quiet in 2015; acts on TRPV1.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Went quiet, 2015
- Kind
- Small molecule
- Registered trials
- 4, 0 stopped early
- Disease areas
- Nervous system; Bones, joints and muscles; Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| TRPV1 | Transient receptor potential cation channel subfamily V member 1 | Q8NER1 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 2 | 2 | 0 | 0 |
| Phase 3 | 2 | 2 | 0 | 0 |
| All trials | 4 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Winston | Lead sponsor of trials | 2002 to now |